Kraft Heinz has closed the holiday-shortened week at its highest price in over the last 10 months. Check out why KHC stock is a buy.
Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results